Rights and permissions
About this article
Cite this article
Abciximab not cost saving in unstable angina pectoris. Pharmacoecon. Outcomes News 200, 8 (1999). https://doi.org/10.1007/BF03295004
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03295004